Терапевтический архив (Feb 2019)

Non-alcoholic fatty liver disease as a cause and consequence of cardio-metabolic complications. Role of the ursodeoxicholic acid in the pharmacotherapy

  • M V Maevskaya,
  • V T Ivashkin,
  • K V Ivashkin,
  • V D Lunkov,
  • E O Liusina,
  • V N Zozula,
  • V I Leshchenko

DOI
https://doi.org/10.26442/00403660.2019.02.000122
Journal volume & issue
Vol. 91, no. 2
pp. 109 – 117

Abstract

Read online

The article presents an update of the role of non-alcoholic fatty liver disease (NAFLD) in cardiometabolic diseases and events: arterial hypertension and components of the metabolic syndrome. A review of NAFLD modern pharmacotherapy has been conducted. Particular attention is paid to the place of ursodeoxycholic acid in the complex treatment of NAFLD.

Keywords